ChampionX (CHX) 10-Q26 Oct 222022 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2022	Oct. 20, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-38441
Entity Registrant Name	ChampionX Corp
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-3066826
Entity Address, Address Line One	2445 Technology Forest Blvd,
Entity Address, Address Line Two	Building 4, 12th Floor
Entity Address, City or Town	The Woodlands,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77381
City Area Code	(281)
Local Phone Number	403-5772
Security 12b Title	Common stock, $0.01 par value
Trading Symbol	CHX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		199,359,754
Entity Central Index Key	0001723089
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue:
Lease and other revenue	$ 22,807	$ 18,337	$ 64,881	$ 55,792
Total revenue	1,021,561	818,785	2,820,093	2,252,845
Cost of goods and services	825,018	623,162	2,204,052	1,714,885
Gross profit	196,543	195,623	616,041	537,960
Costs and expenses:
Selling, general and administrative expense	153,736	135,089	445,447	430,908
Interest expense, net	11,454	12,849	33,582	40,884
Other expense (income), net	(6,118)	(36,876)	27,483	(36,561)
Income before income taxes	37,471	84,561	109,529	102,729
Provision for income taxes	14,246	25,910	19,235	32,255
Net income	23,225	58,651	90,294	70,474
Net income attributable to noncontrolling interest	157	1,823	3,182	624
Net income attributable to ChampionX	$ 23,068	$ 56,828	$ 87,112	$ 69,850
Earnings per share attributable to ChampionX:
Basic (in dollars per share)	$ 0.11	$ 0.28	$ 0.43	$ 0.35
Diluted (in dollars per share)	$ 0.11	$ 0.27	$ 0.42	$ 0.34
Weighted-average shares outstanding:
Weighted-average shares outstanding, basic (in shares)	201,421	201,852	202,600	201,329
Weighted-average shares outstanding, diluted (in shares)	206,522	208,545	208,155	208,173
Product revenue
Revenue:
Revenue	$ 897,156	$ 711,099	$ 2,455,377	$ 1,945,855
Service revenue
Revenue:
Revenue	$ 101,598	$ 89,349	$ 299,835	$ 251,198

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 23,225	$ 58,651	$ 90,294	$ 70,474
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(47,067)	(11,737)	(27,463)	(192)
Cash flow hedges	16,310	3,218	11,608	3,354
Defined pension and other post-retirement benefits adjustments, net	68	46	207	6,586
Other comprehensive income	(30,689)	(8,473)	(15,648)	9,748
Comprehensive income	(7,464)	50,178	74,646	80,222
Less: Comprehensive income (loss) attributable to noncontrolling interest	157	1,823	3,182	624
Comprehensive income attributable to ChampionX	$ (7,621)	$ 48,355	$ 71,464	$ 79,598

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands, shares in Millions	Sep. 30, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 187,472	$ 251,678
Restricted cash	3,500	3,500
Receivables, net	611,501	584,440
Inventories, net	570,820	542,910
Assets held for sale	33,617	7,217
Prepaid expenses and other current assets	69,920	71,155
Total current assets	1,476,830	1,460,900
Property, plant and equipment, net of accumulated depreciation of $659,094 in 2022 and $618,867 in 2021	722,868	776,813
Goodwill	708,460	702,867
Intangible assets, net	326,156	401,470
Operating lease right-of-use assets	88,736	115,458
Other non-current assets	79,730	77,193
Total assets	3,402,780	3,534,701
Current Liabilities:
Current portion of long-term debt	4,688	26,850
Accounts payable	499,371	473,561
Accrued compensation and employee benefits	73,607	93,131
Current portion of operating lease liabilities	28,688	36,389
Accrued distributor fees	59,611	25,621
Liabilities held for sale	9,635	0
Accrued expenses and other current liabilities	121,075	146,773
Total current liabilities	796,675	802,325
Long-term debt	644,029	697,657
Deferred income taxes	100,972	137,971
Operating lease liabilities	55,652	73,521
Other long-term liabilities	110,732	68,920
Total liabilities	1,708,060	1,780,394
Stockholders’ equity:
Common stock (2.5 billion shares authorized, $0.01 par value) 199.3 million shares and 202.9 million shares issued and outstanding in 2022 and 2021, respectively	1,993	2,029
Capital in excess of par value of common stock	2,276,094	2,315,399
Accumulated deficit	(530,128)	(525,158)
Accumulated other comprehensive loss	(37,273)	(21,625)
ChampionX stockholders’ equity	1,710,686	1,770,645
Noncontrolling interest	(15,966)	(16,338)
Total equity	1,694,720	1,754,307
Total liabilities and equity	$ 3,402,780	$ 3,534,701
Common stock, shares issued (in shares)	199.3	202.9
Common stock, shares outstanding (in shares)	199.3	202.9

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Accumulated depreciation on property, plant, and equipment	$ 659,094	$ 618,867
Common stock, shares authorized (in shares)	2,500,000,000	2,500,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares issued (in shares)	199,300,000	202,900,000
Common stock, shares outstanding (in shares)	199,300,000	202,900,000

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock, Par Value	Common Stock, Capital in Excess of Par Value	Accum. Deficit	Accum. Other Comp. Loss	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2020		200,380,000
Beginning balance at Dec. 31, 2020	$ 1,612,575	$ 2,004	$ 2,293,179	$ (638,457)	$ (30,755)	$ (13,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	4,037			5,772		(1,735)
Other comprehensive income (loss)	3,793				3,793
Stock-based compensation (in shares)		64,000
Stock-based compensation	6,442		6,442
Stock options exercised (in shares)		577,000
Stock options exercised	3,347	$ 6	3,341
Taxes withheld on issuance of stock-based awards	(556)		(556)
Cumulative translation adjustments	268					268
Distributions to noncontrolling interest	(800)					(800)
Ending balance (in shares) at Mar. 31, 2021		201,021,000
Ending balance at Mar. 31, 2021	1,629,106	$ 2,010	2,302,406	(632,685)	(26,962)	(15,663)
Beginning balance (in shares) at Dec. 31, 2020		200,380,000
Beginning balance at Dec. 31, 2020	1,612,575	$ 2,004	2,293,179	(638,457)	(30,755)	(13,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	70,474
Other comprehensive income (loss)	9,748
Ending balance (in shares) at Sep. 30, 2021		201,907,000
Ending balance at Sep. 30, 2021	1,711,752	$ 2,019	2,314,592	(568,607)	(21,007)	(15,245)
Beginning balance (in shares) at Mar. 31, 2021		201,021,000
Beginning balance at Mar. 31, 2021	1,629,106	$ 2,010	2,302,406	(632,685)	(26,962)	(15,663)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	7,786			7,250		536
Other comprehensive income (loss)	14,428				14,428
Stock-based compensation (in shares)		101,000
Stock-based compensation	5,914		5,914
Stock options exercised (in shares)		578,000
Stock options exercised	3,162	$ 7	3,155
Taxes withheld on issuance of stock-based awards	(1,208)		(1,208)
Cumulative translation adjustments	(231)					(231)
Ending balance (in shares) at Jun. 30, 2021		201,700,000
Ending balance at Jun. 30, 2021	1,658,957	$ 2,017	2,310,267	(625,435)	(12,534)	(15,358)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	58,651			56,828		1,823
Other comprehensive income (loss)	(8,473)				(8,473)
Stock-based compensation (in shares)		133,000
Stock-based compensation	5,557		5,557
Stock options exercised (in shares)		74,000
Stock options exercised	431	$ 2	429
Taxes withheld on issuance of stock-based awards	(1,661)		(1,661)
Distributions to noncontrolling interest	(1,710)					(1,710)
Ending balance (in shares) at Sep. 30, 2021		201,907,000
Ending balance at Sep. 30, 2021	$ 1,711,752	$ 2,019	2,314,592	(568,607)	(21,007)	(15,245)
Beginning balance (in shares) at Dec. 31, 2021	202,900,000	202,866,000
Beginning balance at Dec. 31, 2021	$ 1,754,307	$ 2,029	2,315,399	(525,158)	(21,625)	(16,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	38,173			36,702		1,471
Other comprehensive income (loss)	(2,795)				(2,795)
Stock-based compensation (in shares)		290,000
Stock-based compensation	4,728	$ 3	4,725
Stock options exercised (in shares)		189,000
Stock options exercised	1,055	$ 1	1,054
Taxes withheld on issuance of stock-based awards	(2,639)		(2,639)
Dividends declared to common stockholders ($0.075 per share)	(15,465)			(15,465)
Cumulative translation adjustments	208					208
Ending balance (in shares) at Mar. 31, 2022		203,345,000
Ending balance at Mar. 31, 2022	$ 1,777,572	$ 2,033	2,318,539	(503,921)	(24,420)	(14,659)
Beginning balance (in shares) at Dec. 31, 2021	202,900,000	202,866,000
Beginning balance at Dec. 31, 2021	$ 1,754,307	$ 2,029	2,315,399	(525,158)	(21,625)	(16,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	90,294
Other comprehensive income (loss)	$ (15,648)
Repurchase and cancellation of common stock (in shares)	(4,487,622)
Repurchase and cancellation of common stock	$ (100,100)
Ending balance (in shares) at Sep. 30, 2022	199,300,000	199,340,000
Ending balance at Sep. 30, 2022	$ 1,694,720	$ 1,993	2,276,094	(530,128)	(37,273)	(15,966)
Beginning balance (in shares) at Mar. 31, 2022		203,345,000
Beginning balance at Mar. 31, 2022	1,777,572	$ 2,033	2,318,539	(503,921)	(24,420)	(14,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	28,896			27,342		1,554
Other comprehensive income (loss)	17,836				17,836
Stock-based compensation (in shares)		64,000
Stock-based compensation	5,071	$ 1	5,070
Stock options exercised (in shares)		312,000
Stock options exercised	2,090	$ 3	2,087
Taxes withheld on issuance of stock-based awards	(739)		(739)
Dividends declared to common stockholders ($0.075 per share)	(15,494)			(15,494)
Repurchase and cancellation of common stock (in shares)		(790,000)
Repurchase and cancellation of common stock	(20,016)	$ (8)	(8,992)	(11,016)
Cumulative translation adjustments	8					8
Distributions to noncontrolling interest	(2,369)					(2,369)
Ending balance (in shares) at Jun. 30, 2022		202,931,000
Ending balance at Jun. 30, 2022	1,792,855	$ 2,029	2,315,965	(503,089)	(6,584)	(15,466)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	23,225			23,068		157
Other comprehensive income (loss)	(30,689)				(30,689)
Stock-based compensation (in shares)		20,000
Stock-based compensation	5,009		5,009
Stock options exercised (in shares)		87,000
Stock options exercised	564	$ 1	563
Taxes withheld on issuance of stock-based awards	(198)		(198)
Dividends declared to common stockholders ($0.075 per share)	$ (15,315)			(15,315)
Repurchase and cancellation of common stock (in shares)	(3,698,106)	(3,698,000)
Repurchase and cancellation of common stock	$ (80,074)	$ (37)	(45,245)	(34,792)
Cumulative translation adjustments	(10)					(10)
Distributions to noncontrolling interest	$ (647)					(647)
Ending balance (in shares) at Sep. 30, 2022	199,300,000	199,340,000
Ending balance at Sep. 30, 2022	$ 1,694,720	$ 1,993	$ 2,276,094	$ (530,128)	$ (37,273)	$ (15,966)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) - $ / shares		3 Months Ended
	Aug. 11, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared to common shareholders (in dollars per share)	$ 0.075	$ 0.075	$ 0.075	$ 0.075

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income	$ 90,294	$ 70,474
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	177,761	178,805
Loss (gain) on disposal group	16,515	(39,876)
Stock-based compensation	14,808	17,913
Provision for inventory obsolescence and write-downs	21,214	5,259
Loss on debt repurchases	4,043	8,707
Deferred income taxes	(37,505)	(10,844)
(Gain) loss on disposal of fixed assets	(4,428)	4,483
Amortization of deferred loan costs and accretion of discount	2,736	2,689
Employee benefit plan expense	1,848	1,853
Other	(587)	(542)
Changes in operating assets and liabilities (net of effects of foreign exchange):
Receivables	(50,075)	(35,435)
Inventories	(72,298)	(74,641)
Prepaid expenses and other current assets	13,737	2,280
Accounts payable	38,600	130,607
Accrued compensation and employee benefits	(20,601)	18,711
Accrued expenses and other liabilities	32,867	(37,361)
Leased assets	(20,947)	(4,496)
Other	10,285	1,214
Net cash flows provided by operating activities	218,267	239,800
Cash flows from investing activities:
Capital expenditures	(74,752)	(67,027)
Proceeds from sale of fixed assets	16,424	4,891
Proceeds from disposal of business	0	68,807
Acquisitions, net of cash acquired	(3,198)	(9,957)
Other	0	(4,874)
Net cash used for investing activities	(61,526)	(8,160)
Cash flows from financing activities:
Proceeds from long-term debt	995,038	0
Repayment of long-term debt	(1,071,386)	(174,392)
Payment of debt issue costs	(8,008)	0
Repurchases of common stock	(100,090)	0
Dividends paid	(30,480)	0
Proceeds from exercise of stock options	3,709	6,940
Payments related to taxes withheld on stock-based compensation	(3,576)	(3,425)
Distributions to noncontrolling interest	(3,016)	(2,510)
Payment of finance lease obligations	(4,503)	(328)
Other	7,111	0
Net cash used for financing activities	(215,201)	(173,715)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(5,746)	(1,991)
Net increase (decrease) in cash and cash equivalents and restricted cash	(64,206)	55,934
Cash and cash equivalents and restricted cash at beginning of period	255,178	201,421
Cash and cash equivalents and restricted cash at end of period	$ 190,972	$ 257,355

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of the Business ChampionX Corporation is a global leader in chemistry solutions and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently and sustainably around the world. Our products provide efficient and safe operations throughout the lifecycle of a well with a focus on the production phase of wells. Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with our subsidiaries where the context requires. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2022. Significant Accounting Policies Please refer to “Note 1 – Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 for the discussion of our significant accounting policies. New Accounting Standards Issued In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations” , which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. We are currently assessing the impact that this ASU will have on our disclosures and will adopt the amendments in this update upon the effective dates.

Segment Information

Segment Information	9 Months Ended
Segment Information	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Information	SEGMENT INFORMATION Our reporting segments are: • Production Chemical Technologies—provides oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues. • Production & Automation Technologies—designs, manufactures, markets and services a full range of artificial lift equipment, end-to-end digital automation solutions, as well as other production equipment and asset monitoring technologies. Production & Automation Technologies’ products are sold under a collection of brands including Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Scientific Aviation, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline, Windrock, and Leak Surveys (“LSI”). • Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings primarily for use in oil and gas drill bits under the US Synthetic brand. • Reservoir Chemical Technologies—manufactures specialty products that support well stimulation, construction (including drilling and cementing) and well intervention in the oil and natural gas industry. We refer to our Production Chemical Technologies segment and our Reservoir Chemical Technologies segment collectively as our Chemical Technologies business. Business activities that do not meet the criteria of an operating segment have been combined into Corporate and other. Corporate and other includes (i) corporate and overhead expenses, and (ii) revenue and costs for activities that are not operating segments. Segment revenue and segment operating profit Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2022 2021 2022 2021 Segment revenue: Production Chemical Technologies $ 643,604 $ 487,670 $ 1,710,987 $ 1,347,090 Production & Automation Technologies 247,717 204,473 710,465 559,491 Drilling Technologies 60,965 49,415 175,682 121,998 Reservoir Chemical Technologies 35,485 38,192 119,499 101,305 Corporate and other (1) 33,790 39,035 103,460 122,961 Total revenue $ 1,021,561 $ 818,785 $ 2,820,093 $ 2,252,845 Segment operating profit (loss): Production Chemical Technologies $ 86,649 $ 45,696 $ 143,518 $ 109,924 Production & Automation Technologies 22,485 14,407 70,845 32,061 Drilling Technologies 14,856 11,146 45,119 21,400 Reservoir Chemical Technologies (61,711) 37,800 (73,327) 31,979 Total segment operating profit 62,279 109,049 186,155 195,364 Corporate and other (1) 13,354 11,639 43,044 51,751 Interest expense, net 11,454 12,849 33,582 40,884 Income before income taxes $ 37,471 $ 84,561 $ 109,529 $ 102,729 _______________________

Revenue

Revenue	9 Months Ended
Revenue	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue	REVENUE Our revenue is generated primarily from product sales. Service revenue is generated from providing services to our customers. These services include installation, repair and maintenance, laboratory and logistics services, chemical management services, troubleshooting, reporting, water treatment services, technical advisory assistance, emissions detection and monitoring, and other field services. Lease revenue is derived from rental income of leased production equipment. As our costs are shared across the various revenue categories, cost of goods sold is not tracked separately and is not discretely identifiable. In certain geographical areas, the Company utilizes joint ventures and independent third-party distributors and sales agents to sell and market products and services. Amounts payable to independent third-party distributors and sales agents may fluctuate based on sales and timing of distributor fee payments. For services rendered by such independent third-party distributors and sales agents, the Company records the consideration received on a net basis within product revenue in our condensed consolidated statements of income. Additionally, amounts owed to distributors and sales agents are reported within accrued distributor fees within our condensed consolidated balance sheets. Revenue disaggregated by geography was as follows: Three Months Ended September 30, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 228,007 $ 192,914 $ 47,645 $ 19,756 $ 19,651 $ 507,973 Latin America 184,964 4,963 7 3,283 758 193,975 Middle East & Africa 77,162 15,567 1,562 8,314 1,358 103,963 Canada 75,334 18,922 4,614 334 49 99,253 Europe 50,206 2,776 5,774 1,102 3,584 63,442 Asia-Pacific 8,851 1,528 1,363 767 8,390 20,899 Australia 5,518 10,803 — 30 — 16,351 Other 13,562 244 — 1,899 — 15,705 Total revenue $ 643,604 $ 247,717 $ 60,965 $ 35,485 $ 33,790 $ 1,021,561 Three Months Ended September 30, 2021 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 163,184 $ 158,534 $ 37,716 $ 26,332 $ 26,890 $ 412,656 Latin America 110,592 4,752 — 3,410 1,048 119,802 Middle East & Africa 66,584 14,243 1,582 4,958 1,467 88,834 Canada 68,907 14,922 3,697 662 43 88,231 Europe 47,891 731 4,459 930 3,529 57,540 Asia-Pacific 11,703 1,853 1,945 1,113 6,058 22,672 Australia 8,693 9,393 — 28 — 18,114 Other 10,116 45 16 759 — 10,936 Total revenue $ 487,670 $ 204,473 $ 49,415 $ 38,192 $ 39,035 $ 818,785 Nine Months Ended September 30, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 624,370 $ 548,698 $ 140,312 $ 76,015 $ 61,544 $ 1,450,939 Latin America 409,109 16,324 7 10,094 2,388 437,922 Middle East & Africa 227,234 51,340 4,471 21,596 1,959 306,600 Canada 223,714 55,858 11,032 1,445 112 292,161 Europe 145,116 8,505 14,640 2,973 10,352 181,586 Asia-Pacific 26,852 3,983 5,180 2,721 27,105 65,841 Australia 16,321 25,386 15 229 — 41,951 Other 38,271 371 25 4,426 — 43,093 Total revenue $ 1,710,987 $ 710,465 $ 175,682 $ 119,499 $ 103,460 $ 2,820,093 Nine Months Ended September 30, 2021 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 469,900 $ 426,246 $ 93,515 $ 61,530 $ 83,132 $ 1,134,323 Latin America 275,597 13,924 — 10,016 3,740 303,277 Middle East & Africa 191,167 38,346 3,744 17,554 8,534 259,345 Canada 193,838 42,204 9,510 1,768 325 247,645 Europe 131,545 4,504 9,236 3,420 9,476 158,181 Asia-Pacific 32,757 6,059 4,351 3,626 17,754 64,547 Australia 21,082 28,151 130 112 — 49,475 Other 31,204 57 1,512 3,279 — 36,052 Total revenue $ 1,347,090 $ 559,491 $ 121,998 $ 101,305 $ 122,961 $ 2,252,845 ______________________ (1) Revenues associated with sales under the Cross Supply and Product Transfer Agreement with Ecolab are included within Corporate and other. Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user. Contract Balances The beginning and ending contract asset and contract liability balances from contracts with customers were as follows: (in thousands) September 30, 2022 December 31, 2021 Contract assets $ — $ — Contract liabilities - current $ 13,660 $ 15,246

Intangible Assets and Goodwill

Intangible Assets and Goodwill	9 Months Ended
Intangible Assets and Goodwill	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	INTANGIBLE ASSETS AND GOODWILL Intangible Assets The components of our definite- and indefinite-lived intangible assets were as follows: September 30, 2022 December 31, 2021 (in thousands) Gross Accumulated Net Gross Accumulated Net Definite-lived Customer relationships $ 581,504 $ 395,810 $ 185,694 $ 593,242 $ 365,773 $ 227,469 Unpatented technologies 142,845 51,624 91,221 142,540 37,264 105,276 Favorable supply agreements 57,000 44,290 12,710 59,000 30,546 28,454 Trademarks 59,852 35,095 24,757 59,873 32,270 27,603 Patents 38,025 31,100 6,925 38,735 31,080 7,655 Other 5,242 5,193 49 5,390 5,177 213 884,468 563,112 321,356 898,780 502,110 396,670 Indefinite-lived Trademarks 3,600 — 3,600 3,600 — 3,600 In-process research and development 1,200 — 1,200 1,200 — 1,200 4,800 — 4,800 4,800 — 4,800 Total $ 889,268 $ 563,112 $ 326,156 $ 903,580 $ 502,110 $ 401,470 Goodwill The carrying amount of goodwill, including changes therein, by reportable segment is below: (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total December 31, 2021 $ 356,638 $ 205,467 $ 101,136 $ 39,626 $ 702,867 Acquisition (1) — 6,345 — — 6,345 Allocated to disposal group (2) (3,271) — — — (3,271) Foreign currency translation 3,192 (665) — (8) 2,519 September 30, 2022 $ 356,559 $ 211,147 $ 101,136 $ 39,618 $ 708,460 _______________________ (1) See Note 11—Acquisitions and Divestitures for additional information related to the acquisition of LSI completed during the first quarter of 2022. (2) See Note 11—Acquisitions and Divestitures for additional information on the reclassification of assets and liabilities held for sale as part of the planned divestiture of our operations in Russia. Goodwill is not subject to amortization but is tested for impairment on an annual basis or more frequently if impairment indicators arise.

Debt

Debt	9 Months Ended
Debt	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt	DEBT Long-term debt consisted of the following: (in thousands) September 30, 2022 December 31, 2021 2022 Revolving Credit Facility $ 45,000 $ — 2018 Term Loan Facility — 140,000 2020 Term Loan Facility — 496,725 2022 Term Loan Facility 625,000 — 6.375% Senior Notes due 2026 — 92,041 Total 670,000 728,766 Net unamortized discounts and issuance costs (21,283) (4,259) Total long-term debt 648,717 724,507 Current portion of long-term debt (1) (4,688) (26,850) Long-term debt, less current portion $ 644,029 $ 697,657 _______________________ (1) Represents the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of September 30, 2022 and 2020 Term Loan Facility as of December 31, 2021. On May 9, 2018, we entered into a credit agreement (“Credit Agreement”) governing the terms of, among other things, a 7-year senior secured term loan B facility that had an initial commitment of $415 million (the “2018 Term Loan Facility”), and on June 3, 2020, ChampionX Holding Inc. entered into a term loan facility for $537.0 million (the “2020 Term Loan Facility”). On June 7, 2022, we entered into a restated credit agreement (the “Restated Credit Agreement”), which amends and restates the Credit Agreement. The Restated Credit Agreement provides for (i) a $625 million 7-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700 million, of which $100 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility,” together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022, with the aggregate proceeds used to repay outstanding amounts under our Credit Agreement, repay and terminate our 2020 Term Loan Facility, and to redeem all outstanding 6.375% Senior Notes due 2026 (the “Notes”). Proceeds from future borrowings under the 2022 Revolving Credit Facility are expected to be used for working capital and general corporate purposes. The initial amount drawn on the 2022 Revolving Credit Facility has been repaid. As of September 30, 2022, we had $45.0 million outstanding on the 2022 Revolving Credit Facility. The 2022 Term Loan Facility matures June 7, 2029 and the 2022 Revolving Credit Facility matures June 7, 2027. The 2022 Term Loan Facility is subject to mandatory amortization payments of 1% per annum of the initial commitment paid quarterly, which begins on December 30, 2022. The Senior Secured Credit Facility contains customary representations and warranties, covenants, and events of default for loan facilities of this type. We were in compliance with all covenants as of September 30, 2022. At the Company’s election, outstanding borrowings under the Senior Secured Credit Facility will accrue interest at a per annum rate of (i) an adjusted SOFR rate plus the applicable spread or (ii) a base rate plus the applicable spread. On June 29, 2022, the Company executed a five-year amortizing floating-to-fixed interest rate swap to hedge our exposure to increases in variable interest rates on the 2022 Term Loan Facility. This interest rate swap agreement is based on a $300 million notional amount for the first three years, reducing to $150 million for years four and five. See Note 13—Derivatives and Hedging Transactions for additional information on interest rate swaps. In connection with the Restated Credit Agreement, as noted above, we completed the redemption of all of the remaining Notes at 103.188% of the principal amount thereof. We redeemed $92.0 million in aggregate principal amount of the Notes for $95.6 million in cash, including $0.6 million in accrued interest. In connection with these redemptions, we recognized a net loss of approximately $3.9 million for the nine months ended September 30, 2022, inclusive of the write off of the remaining unamortized debt financing costs related to the Notes, which is included in other expense, net in our condensed consolidated statements of income (loss).

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Guarantees and Indemnifications We have provided indemnities in connection with sales of certain businesses and assets, including indemnities for environmental health and safety, tax, and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities. In connection with the Company’s separation from Dover Corporation (“Dover”) in 2018, we entered into agreements with Dover that govern the treatment between Dover and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Dover’s business with Dover. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters. In connection with the acquisition of the Chemical Technologies business from Ecolab in 2020 (the “Merger”), we entered into agreements with Ecolab that govern the treatment between Ecolab and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Ecolab’s business with Ecolab. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters. In addition, pursuant to the tax matters agreement relating to the Merger (the “Tax Matters Agreement”), we have agreed to indemnify Ecolab and its affiliates for (i) all taxes for which ChampionX is responsible as defined within the Tax Matters Agreement, (ii) all taxes resulting from a breach by ChampionX of any of its representations (but only to the extent relating to a breach occurring after the consummation of the Merger) or any of its covenants under the Tax Matters Agreement, (iii) all taxes resulting from an acquisition after the Merger of any of the stock or assets of ChampionX, other than as a result of the Merger or a repayment of the 2018 Credit Facility (as defined in “Note 8–Debt” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021), 2018 Term Loan Facility or 2020 Term Loan Facility and (iv) reasonable costs and expenses (including reasonable attorneys’ fees and expenses) related to the foregoing. As of September 30, 2022 and December 31, 2021, we had $73.0 million and $80.2 million, respectively, of outstanding letters of credit, surety bonds and guarantees, which expire at various dates through 2039. These financial instruments are primarily maintained as security for insurance, warranty, and other performance obligations. Generally, we would only be liable for the amount of these letters of credit, surety bonds, and guarantees in the event of default in the performance of our obligations, the probability of which we believe is remote. Litigation and Environmental Matters The Company is party to various proceedings and claims incidental to its business, including matters arising under provisions relating to the protection of the environment. We review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. While many of these matters involve inherent uncertainty, we believe that the amount of the liability, if any, ultimately incurred with respect to these proceedings and claims will not have a material adverse effect on our consolidated financial position, results of operations or cash flows. Environmental Matters The Company is currently participating in environmental assessments and remediation at approximately 11 locations, the majority of which are in the United States (“U.S.”), and environmental liabilities have been accrued reflecting our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of September 30, 2022 and December 31, 2021, environmental liability accruals related to these locations were $6.1 million and $6.8 million, respectively. Prior to the separation from Dover in 2018, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma (“Norris”). Initial remedial efforts were undertaken at the time of discovery of the contamination and Norris has since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality (“ODEQ”). As part of the ongoing long-term remediation process, Norris contracted an engineering and consulting firm to develop a range of possible additional remedial alternatives in order to accelerate the remediation process and associated cost estimates for the work. In October 2019, we received the firm’s preliminary remedial alternatives for consideration. We have submitted our long-term remediation plan and it was approved by ODEQ. We are now in discussion with ODEQ to finalize a consent order. Because we have not yet finalized the consent order for further remediation at the site and discussions with ODEQ remain ongoing, we cannot fully anticipate the timing, outcome or possible impact of such further remedial activities, financial or otherwise. As a result of the recommendations in the report, we accrued liabilities for these remediation efforts of approximately $2.0 million as of December 31, 2019. Liabilities could increase in the future at such time as we ultimately reach agreement with ODEQ on our remediation plan and such liabilities become probable and can be reasonably estimated; however, there have been no changes to our estimated liability as of September 30, 2022. Matters Related to Deepwater Horizon Incident Response On April 22, 2010, the deepwater drilling platform, the Deepwater Horizon, operated by a subsidiary of BP plc, sank in the Gulf of Mexico after an explosion and fire, resulting in a massive oil spill. Certain entities that are now subsidiaries of ChampionX as a result of the Merger (collectively the “COREXIT Defendants”) supplied COREXIT™ 9500, an oil dispersant product listed on the U.S. EPA National Contingency Plan Product Schedule, which was used in the response to the spill. In connection with the provision of COREXIT™ 9500, the COREXIT Defendants were named in several lawsuits. Cases arising out of the Deepwater Horizon accident were administratively transferred and consolidated for pre-trial purposes under In Re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, Case No. 10-md-02179 in the United States District Court in the Eastern District of Louisiana (E.D. La.) (“MDL 2179”). Claims related to the response to the oil spill were consolidated in a master complaint captioned the “B3 Master Complaint.” In 2011, Transocean Deepwater Drilling, Inc. and its affiliates (the “Transocean Entities”) named the COREXIT Defendants and other unaffiliated companies as first party defendants (In re the Complaint and Petition of Triton Asset Leasing GmbH, et al, MDL No. 2179, Civil Action 10-2771). In April and May 2011, the Transocean Entities, Cameron International Corporation, Halliburton Energy Services, Inc., M-I L.L.C., Weatherford U.S., L.P. and Weatherford International, Inc. (collectively, the “Cross Claimants”) filed cross claims in MDL 2179 against the COREXIT Defendants and other unaffiliated cross defendants. In April and June 2011, in support of its defense of the claims against it, the COREXIT Defendants filed counterclaims against the Cross Claimants. On May 18, 2012, the COREXIT Defendants filed a motion for summary judgment as to the claims in the B3 Master Complaint. On November 28, 2012, the Court granted the COREXIT Defendants’ motion and dismissed with prejudice the claims in the B3 Master Complaint asserted against the COREXIT Defendants. There currently remain two “B3” cases that had asserted claims against the COREXIT Defendants and that remain pending against other defendants. Because the Court’s decision was not a “final judgment” for purposes of appeal with respect to those claims, under Federal Rule of Appellate Procedure 4(a), plaintiffs will have 30 days after entry of final judgment in each case to appeal the Court’s summary judgment decision. The Company believes the claims asserted against the COREXIT Defendants are without merit and intends to defend these lawsuits vigorously. The Company also believes that it has rights to contribution and/or indemnification (including legal expenses) from third parties. However, we cannot predict the outcome of these lawsuits, the involvement it might have in these matters in the future, or the potential for future litigation.

Restructuring and Other Related

Restructuring and Other Related Charges	9 Months Ended
Restructuring and Other Related Charges	Sep. 30, 2022
Restructuring and Related Activities [Abstract]
Restructuring and Other Related Charges	RESTRUCTURING AND OTHER RELATED CHARGES We approved various restructuring plans related to the consolidation of product lines and associated facility closures and workforce reductions during the current and prior periods. During the second quarter of 2022, the restructuring plans included the exit of one of our product lines within the Reservoir Chemical Technologies segment. The exit of this product line was completed during the third quarter of 2022 and as such, we recognized additional restructuring charges primarily related to certain contract termination costs as well as the exit of facilities. Liabilities for these contract termination costs are recognized and measured at fair value in the period in which we cease using the rights conveyed by the existing contracts. The liability will be paid out over the remaining term of the contracts, ranging from approximately 1 – 8 years. We recognized charges of $69.8 million and $84.9 million during the three and nine months ended September 30, 2022, respectively, consisting primarily of contract termination costs, employee severance and related benefits, disposals of equipment and warehouse closures, partially offset by gains realized on the sale of facilities. During the three and nine months ended September 30, 2021, we recorded restructuring and other charges of $2.1 million and $10.1 million, respectively. The following table presents the restructuring and other related charges by segment as classified in our condensed consolidated statements of income. Three Months Ended Nine Months Ended (in thousands) 2022 2021 2022 2021 Segment restructuring charges (income): Production Chemical Technologies $ (335) $ 1,031 $ 11,637 $ 4,822 Production & Automation Technologies 4,282 947 260 4,903 Drilling Technologies — — — — Reservoir Chemical Technologies 63,458 65 69,559 307 Corporate and other 2,350 44 3,403 86 Total $ 69,755 $ 2,087 $ 84,859 $ 10,118 Statements of Income classification: Cost of goods and services $ 66,488 $ 802 $ 67,496 $ 4,708 Selling, general and administrative expense 3,267 1,285 17,363 5,410 Total $ 69,755 $ 2,087 $ 84,859 $ 10,118 Our liability balance for restructuring and other related charges at September 30, 2022 reflects contract termination costs, employee severance and related benefits initiated during the period. Additional programs may be initiated during the remainder of 2022 with related restructuring charges. The following table details our restructuring accrual activities during the nine months ended September 30, 2022: (in thousands) Restructuring Accrual Balance December 31, 2021 $ 3,743 Restructuring charges 84,859 Asset sales (13,235) Payments (13,771) Other, including foreign currency translation (66) September 30, 2022 $ 61,530

Equity and Cash Incentive Progr

Equity and Cash Incentive Programs	9 Months Ended
Equity and Cash Incentive Programs	Sep. 30, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Equity and Cash Incentive Programs	EQUITY AND CASH INCENTIVE PROGRAMS Stock-based compensation expense is reported within selling, general and administrative expense in the condensed consolidated statements of income. Stock-based compensation expense relating to all stock-based incentive plans was as follows: Three Months Ended Nine Months Ended (in thousands) 2022 2021 2022 2021 Stock-based compensation expense $ 5,009 $ 5,557 $ 14,808 $ 17,913 Tax benefit (1,052) (1,167) (3,110) (3,762) Stock-based compensation expense, net of tax $ 3,957 $ 4,390 $ 11,698 $ 14,151 A summary of activity relating to our share-based awards for the nine months ended September 30, 2022 was as follows: (in shares) Stock-Settled Appreciation Rights Performance Share Awards Restricted Stock Units Non-Qualified Stock Options Outstanding at January 1, 2022 393,523 505,509 2,342,107 5,488,653 Granted — 347,920 945,616 — Forfeited / expired (1,758) (6,022) (226,671) (2,859) Exercised / vested — (72,410) (466,898) (586,064) Outstanding at September 30, 2022 391,765 774,997 2,594,154 4,899,730

Stockholders' Equity

Stockholders' Equity	9 Months Ended
Stockholders' Equity	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Stockholders' Equity	STOCKHOLDERS' EQUITY Dividends On February 4, 2022, our Board of Directors (“Board”) approved a plan to initiate a regular quarterly cash dividend of $0.075 per share of the Company’s common stock. Our third quarter cash dividend of $0.075 per share was declared on August 11, 2022, and is payable on October 28, 2022 to stockholders of record on October 7, 2022. As a result, we recorded a dividend payable of $15.8 million on our condensed consolidated balance sheet as of September 30, 2022. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors. Repurchases On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock. On October 24, 2022, our Board increased the authorization under this program to $750 million. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock. During the three months ended September 30, 2022, we repurchased and cancelled 3,698,106 shares of common stock at a volume-weighted average price of $21.63 per share for a total of $80.1 million, including commissions. During the nine months ended September 30, 2022, we repurchased and cancelled 4,487,622 shares of common stock at a volume-weighted average price of $22.28 per share for a total of $100.1 million, including commissions. Accumulated other comprehensive loss Accumulated other comprehensive loss —Accumulated other comprehensive loss consisted of the following: (in thousands) Foreign Currency Translation Defined Pension and Other Post-Retirement Benefits Cash Flow Hedges Accumulated Other Comprehensive Loss December 31, 2021 $ (19,430) $ (3,476) $ 1,281 $ (21,625) Other comprehensive loss before reclassifications, net of tax (1,565) — (1,299) (2,864) Reclassification adjustment for net losses included in net income, net of tax — 69 — 69 Other comprehensive loss, net of tax (1,565) 69 (1,299) (2,795) March 31, 2022 $ (20,995) $ (3,407) $ (18) $ (24,420) Other comprehensive income before reclassifications, net of tax 21,169 — (3,403) 17,766 Reclassification adjustment for net losses included in net income, net of tax — 70 — 70 Other comprehensive income, net of tax 21,169 70 (3,403) 17,836 June 30, 2022 $ 174 $ (3,337) $ (3,421) $ (6,584) Other comprehensive income before reclassifications, net of tax $ (47,067) $ — $ 16,310 $ (30,757) Reclassification adjustment for net losses included in net income, net of tax $ — $ 68 $ — $ 68 Other comprehensive income, net of tax (47,067) 68 16,310 (30,689) September 30, 2022 $ (46,893) $ (3,269) $ 12,889 $ (37,273) (in thousands) Foreign Currency Translation Defined Pension and Other Post-Retirement Benefits Cash Flow Hedges Accumulated Other Comprehensive Loss December 31, 2020 $ (14,965) $ (13,470) $ (2,320) $ (30,755) Other comprehensive income before reclassifications, net of tax 3,213 — 413 3,626 Reclassification adjustment for net losses included in net income, net of tax — 167 — 167 Other comprehensive income, net of tax 3,213 167 413 3,793 March 31, 2021 $ (11,752) $ (13,303) $ (1,907) $ (26,962) Other comprehensive income (loss) before reclassifications, net of tax 8,332 — (277) 8,055 Reclassification adjustment for net losses included in net income, net of tax — 6,373 — 6,373 Other comprehensive income (loss), net of tax 8,332 6,373 (277) 14,428 June 30, 2021 $ (3,420) $ (6,930) $ (2,184) $ (12,534) Other comprehensive income (loss) before reclassifications, net of tax (11,737) — 3,218 (8,519) Reclassification adjustment for net losses included in net income, net of tax — 46 — 46 Other comprehensive income (loss), net of tax (11,737) 46 3,218 (8,473) September 30, 2021 $ (15,157) $ (6,884) $ 1,034 $ (21,007) Reclassifications from accumulated other comprehensive loss —Reclassification adjustments from accumulated other comprehensive loss to net income (loss) related to defined pension and other post-retirement benefits consisted of the following: Three Months Ended Nine Months Ended Affected line items on the condensed consolidated statements of income (loss) (in thousands) 2022 2021 2022 2021 Pensions and other post-retirement benefits: Amortization of actuarial loss and other $ 68 $ 46 $ 207 $ 6,586 Other expense (income), net Total before tax 68 46 207 6,586 Income before income taxes Tax benefit — — — — Provision for income taxes Net of tax $ 68 $ 46 $ 207 $ 6,586 Net income

Earnings Per Share

Earnings Per Share	9 Months Ended
Earnings Per Share	Sep. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Share	EARNINGS PER SHARE A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands, except per share data) 2022 2021 2022 2021 Net income attributable to ChampionX $ 23,068 $ 56,828 $ 87,112 $ 69,850 Weighted-average number of shares outstanding 201,421 201,852 202,600 201,329 Dilutive effect of stock-based compensation 5,101 6,693 5,555 6,844 Total shares and dilutive securities 206,522 208,545 208,155 208,173 Earnings per share attributable to ChampionX: Basic $ 0.11 $ 0.28 $ 0.43 $ 0.35 Diluted $ 0.11 $ 0.27 $ 0.42 $ 0.34 For all periods presented, the computation of diluted earnings per share excludes awards with an anti-dilutive impact. For the three and nine months ended September 30, 2022, the diluted shares include the dilutive impact of equity awards except for approximately 0.4 million and 0.4 million shares, respectively, that were excluded because their inclusion would be anti-dilutive. For the three and nine months ended September 30, 2021, the diluted shares include the dilutive impact of equity awards except for approximately 0.5 million and 0.6 million shares, respectively, that were excluded because their inclusion would be anti-dilutive.

Acquisitions and Divestitures

Acquisitions and Divestitures	9 Months Ended
Acquisitions and Divestitures	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions and Divestitures	ACQUISITIONS AND DIVESTITURES Acquisitions On February 23, 2022, we acquired LSI, a leader in optical gas imaging technology that provides aerial and ground-based emissions leak detection to the oil and gas industry. LSI has been included in our Production & Automation Technologies segment. Under the terms of the agreement, we paid an initial amount of $3.2 million, net of cash acquired, with an additional $0.5 million payable on the first anniversary of the closing date. We may also be required to make future payments of up to an additional $2.5 million, contingent on the future performance of the business. As part of our purchase price allocation, we recorded goodwill of $6.3 million. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements. Divestitures Given the continued economic pressure and sanctions imposed by the United States, European Union, and United Kingdom, we initiated a plan to dispose of our operations in Russia (the “CT Russia Business”), which is included in our Production Chemical Technologies segment. As a result, the CT Russia Business met the criteria to be classified as held for sale as of June 30, 2022, which required us to present the related assets and liabilities as separate line items in our condensed consolidated balance sheet. We recorded an initial charge of $22.9 million during the second quarter of 2022, in order to properly reflect the carrying value of the disposal group at the lower of its carrying value or fair value less any costs to sell. We assess the fair value of a long-lived asset or disposal group (less any costs to sell) each reporting period that it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale. During the three months ended September 30, 2022, we recognized a gain of $6.4 million to adjust the carrying value of the disposal group. Upon the ultimate disposition, we will recognize the cumulative translation adjustment balance associated with the CT Russia Business in our condensed consolidated statement of income as part of the gain or loss on the sale. The following table presents information related to the major classes of assets and liabilities of the CT Russia Business that were held for sale in our condensed consolidated balance sheet: (in thousands) Receivables $ 8,330 Inventory 6,638 Prepaid expenses and other current assets 3,078 Property, plant, and equipment 4,721 Goodwill 3,271 Intangible assets 6,927 Operating lease right-of-use assets 2,001 Loss on disposal group (16,515) Total assets held for sale $ 18,451 Accounts payable $ 2,168 Other current liabilities 3,933 Other noncurrent liabilities 3,257 Total liabilities held for sale $ 9,358

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	FAIR VALUE MEASUREMENTS Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels: Level 1 - Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2 - Inputs include observable inputs other than quoted prices in active markets. Level 3 - Inputs are unobservable inputs for which there is little or no market data available. The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows: Carrying Amount (in thousands) Measurement Level September 30, 2022 December 31, 2021 Assets Foreign currency forward contracts Level 2 $ 17,074 $ 4,081 Interest rate swaps Level 2 8,885 — Total $ 25,959 $ 4,081 Liabilities Foreign currency forward contracts Level 2 $ 11,989 $ 3,773 Interest rate swaps Level 2 133 — Total $ 12,122 $ 3,773 For purposes of fair value disclosure above, derivative values are presented gross. See Note 13—Derivatives and Hedging Transactions for further discussion of gross versus net presentation of the Company’s derivatives. The carrying amounts of cash and cash equivalents, trade receivables, accounts payable, as well as amounts included in other current assets and other current liabilities that meet the definition of financial instruments, approximate fair value due to their short-term nature. The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were: September 30, 2022 December 31, 2021 (in thousands) Carrying Amount Fair Value Carrying Amount Fair Value 2022 Revolving Credit Facility $ 45,000 $ 45,000 $ — $ — 2018 Term Loan Facility $ — $ — $ 140,000 $ 138,950 2020 Term Loan Facility $ — $ — $ 496,725 $ 502,313 2022 Term Loan Facility $ 625,000 $ 609,375 $ — $ — 6.375% Senior Notes due 2026 $ — $ — $ 92,041 $ 95,805

Derivatives and Hedging Transac

Derivatives and Hedging Transactions	9 Months Ended
Derivatives and Hedging Transactions	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives and Hedging Transactions	DERIVATIVES AND HEDGING TRANSACTIONS The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company also utilizes floating-to-fixed interest rate swap agreements as cash flow hedges on certain debt, to mitigate interest rate risk. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. Derivative contracts are recorded as assets and liabilities on the balance sheet at fair value. We evaluated the interest rate swap hedge effectiveness and determined it to be perfectly effective. We evaluate foreign currency forward contracts hedge effectiveness at contract inception and thereafter on a quarterly basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Changes in fair value attributable to changes in spot exchange rates for derivative contracts that have been designated as cash flow hedges are recognized in accumulated other comprehensive income (loss) (“AOCI”) and reclassified into earnings in the same period the hedged transaction affects earnings and are presented in the same income statement line as the earnings effect of the hedged item. The Company accounts for the interest rate swap agreements as a cash flow hedge, thus the effective portion of gains and losses resulting from changes in fair value are recognized in AOCI and are amortized to interest expense over the term of the respective debt. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships. The Company is exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swaps. We monitor our exposure to credit risk by using major global banks and financial institutions as counterparties and monitoring their financial condition and credit profile. The Company does not anticipate nonperformance by any of these counterparties, and therefore, recording a valuation allowance against the Company’s derivative balance is not considered necessary. Derivative Positions Summary Certain of the Company’s derivative transactions are subject to master netting arrangements that allow the Company to settle with the same counterparties. These arrangements generally do not call for collateral and as of the applicable dates presented in the following table, no cash collateral had been received or pledged related to the underlying derivatives. We have elected to present our derivative balances on a gross basis on the condensed consolidated balance sheet. The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet. Derivative Assets Derivative Liabilities (in thousands) September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 Prepaid expenses and other current assets $ 20,027 $ 4,081 $ — $ — Other non-current assets 5,932 — — — Accrued expenses and other current liabilities — — 12,122 3,773 Other long-term liabilities — — — — $ 25,959 $ 4,081 $ 12,122 $ 3,773 The following table summarizes the notional values of the Company’s outstanding derivatives: (in thousands) September 30, 2022 December 31, 2021 Notional value of foreign currency forward contracts and interest rate swaps $ 953,246 $ 704,190 Cash Flow Hedges The Company utilizes foreign currency forward contracts to hedge the effect of foreign currency exchange rate fluctuations on forecasted foreign currency transactions, primarily related to inventory purchases. These forward contracts are designated as cash flow hedges. The changes in fair value of these contracts attributable to changes in spot exchange rates are recorded in AOCI until the hedged items affect earnings, at which time the gain or loss is reclassified into the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged. The forward points are marked-to-market monthly and recognized in the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged. Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount. Any unrealized gain or loss at the time of settlement will be reclassified to interest expense, where we record the interest expense on the associated debt. Derivatives Not Designated as Hedging Instruments The Company also uses foreign currency forward contracts to offset its exposure to the change in value of certain foreign currency denominated assets and liabilities, primarily receivables and payables, which are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Therefore, changes in the value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities. Effect of Derivative Instruments on Income The loss of all derivative instruments recognized is summarized below: Three Months Ended Nine Months Ended (in thousands) 2022 2021 2022 2021 Loss (gain) reclassified from AOCI to income on cash flow hedges: Cost of goods and services $ (837) $ 1,447 $ (884) $ 3,219 Interest expense 585 — 585 — Loss on derivatives not designated as hedging instruments: Other (income) expense, net 1,167 955 6,578 2,417 Total loss of derivative instruments $ 915 $ 2,402 $ 6,279 $ 5,636

Inventories

Inventories	9 Months Ended
Inventories	Sep. 30, 2022
Inventory, Net [Abstract]
Inventories	INVENTORIES Inventories consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Raw materials $ 148,119 $ 186,516 Work in progress 20,363 13,615 Finished goods 523,042 421,702 691,524 621,833 Inventory reserve (26,927) (24,646) LIFO adjustments (1) (93,777) (54,277) Inventories, net $ 570,820 $ 542,910 _______________________ (1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.

Accounts Receivable Facility

Accounts Receivable Facility	9 Months Ended
Accounts Receivable Facility	Sep. 30, 2022
Receivables [Abstract]
Accounts Receivable Facility	ACCOUNTS RECEIVABLE FACILITY On June 28, 2022, we entered into an uncommitted accounts receivable purchase agreement (the “Accounts Receivable Facility”) with JPMorgan Chase Bank, N.A. as the purchaser. Transfers under the Accounts Receivable Facility are accounted for as sales of receivables, resulting in the receivables being derecognized from our consolidated balance sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign or transfer (including as a participation interest) any of its rights under the purchased receivables to another bank or financial institution. The amount available for sale under the Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. A maximum of $160.0 million in receivables may be sold and remain unpaid under the Accounts Receivable Facility at any time. Accounts receivable sold were $101.2 million for the three and nine months ended September 30, 2022. The accounts receivable sold that remained outstanding as of September 30, 2022 was $60.0 million. During these periods, cash receipts from the purchaser at the time of the sale were classified as operating activities in our condensed consolidated statement of cash flows. The difference between the carrying amount of the accounts receivable sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense), net in our condensed consolidated statements of income. The loss on sale of accounts receivable was $0.7 million for the three and nine months ended September 30, 2022.

Cash Flow Information

Cash Flow Information	9 Months Ended
Cash Flow Information	Sep. 30, 2022
Supplemental Cash Flow Elements [Abstract]
Cash Flow Information	CASH FLOW INFORMATION Leased Asset Program Our electrical submersible pumping (“ESP”) leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our leased asset program. During the nine months ended September 30, 2022 and September 30, 2021, we transferred $32.1 million and $33.9 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our leased asset program.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2022.
New Accounting Standards Issued	New Accounting Standards Issued In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations” , which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. We are currently assessing the impact that this ASU will have on our disclosures and will adopt the amendments in this update upon the effective dates.
Fair Value Measurements	Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels: Level 1 - Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2 - Inputs include observable inputs other than quoted prices in active markets. Level 3 - Inputs are unobservable inputs for which there is little or no market data available.

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
Segment Information (Tables)	Sep. 30, 2022
Segment Reporting [Abstract]
Schedule of Segment Revenue and Operating Profit	Segment revenue and segment operating profit Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2022 2021 2022 2021 Segment revenue: Production Chemical Technologies $ 643,604 $ 487,670 $ 1,710,987 $ 1,347,090 Production & Automation Technologies 247,717 204,473 710,465 559,491 Drilling Technologies 60,965 49,415 175,682 121,998 Reservoir Chemical Technologies 35,485 38,192 119,499 101,305 Corporate and other (1) 33,790 39,035 103,460 122,961 Total revenue $ 1,021,561 $ 818,785 $ 2,820,093 $ 2,252,845 Segment operating profit (loss): Production Chemical Technologies $ 86,649 $ 45,696 $ 143,518 $ 109,924 Production & Automation Technologies 22,485 14,407 70,845 32,061 Drilling Technologies 14,856 11,146 45,119 21,400 Reservoir Chemical Technologies (61,711) 37,800 (73,327) 31,979 Total segment operating profit 62,279 109,049 186,155 195,364 Corporate and other (1) 13,354 11,639 43,044 51,751 Interest expense, net 11,454 12,849 33,582 40,884 Income before income taxes $ 37,471 $ 84,561 $ 109,529 $ 102,729 _______________________

Revenue (Tables)

Revenue (Tables)	9 Months Ended
Revenue (Tables)	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Revenue disaggregated by geography was as follows: Three Months Ended September 30, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 228,007 $ 192,914 $ 47,645 $ 19,756 $ 19,651 $ 507,973 Latin America 184,964 4,963 7 3,283 758 193,975 Middle East & Africa 77,162 15,567 1,562 8,314 1,358 103,963 Canada 75,334 18,922 4,614 334 49 99,253 Europe 50,206 2,776 5,774 1,102 3,584 63,442 Asia-Pacific 8,851 1,528 1,363 767 8,390 20,899 Australia 5,518 10,803 — 30 — 16,351 Other 13,562 244 — 1,899 — 15,705 Total revenue $ 643,604 $ 247,717 $ 60,965 $ 35,485 $ 33,790 $ 1,021,561 Three Months Ended September 30, 2021 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 163,184 $ 158,534 $ 37,716 $ 26,332 $ 26,890 $ 412,656 Latin America 110,592 4,752 — 3,410 1,048 119,802 Middle East & Africa 66,584 14,243 1,582 4,958 1,467 88,834 Canada 68,907 14,922 3,697 662 43 88,231 Europe 47,891 731 4,459 930 3,529 57,540 Asia-Pacific 11,703 1,853 1,945 1,113 6,058 22,672 Australia 8,693 9,393 — 28 — 18,114 Other 10,116 45 16 759 — 10,936 Total revenue $ 487,670 $ 204,473 $ 49,415 $ 38,192 $ 39,035 $ 818,785 Nine Months Ended September 30, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 624,370 $ 548,698 $ 140,312 $ 76,015 $ 61,544 $ 1,450,939 Latin America 409,109 16,324 7 10,094 2,388 437,922 Middle East & Africa 227,234 51,340 4,471 21,596 1,959 306,600 Canada 223,714 55,858 11,032 1,445 112 292,161 Europe 145,116 8,505 14,640 2,973 10,352 181,586 Asia-Pacific 26,852 3,983 5,180 2,721 27,105 65,841 Australia 16,321 25,386 15 229 — 41,951 Other 38,271 371 25 4,426 — 43,093 Total revenue $ 1,710,987 $ 710,465 $ 175,682 $ 119,499 $ 103,460 $ 2,820,093 Nine Months Ended September 30, 2021 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 469,900 $ 426,246 $ 93,515 $ 61,530 $ 83,132 $ 1,134,323 Latin America 275,597 13,924 — 10,016 3,740 303,277 Middle East & Africa 191,167 38,346 3,744 17,554 8,534 259,345 Canada 193,838 42,204 9,510 1,768 325 247,645 Europe 131,545 4,504 9,236 3,420 9,476 158,181 Asia-Pacific 32,757 6,059 4,351 3,626 17,754 64,547 Australia 21,082 28,151 130 112 — 49,475 Other 31,204 57 1,512 3,279 — 36,052 Total revenue $ 1,347,090 $ 559,491 $ 121,998 $ 101,305 $ 122,961 $ 2,252,845 ______________________
Schedule of Contract Balances	The beginning and ending contract asset and contract liability balances from contracts with customers were as follows: (in thousands) September 30, 2022 December 31, 2021 Contract assets $ — $ — Contract liabilities - current $ 13,660 $ 15,246

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	9 Months Ended
Intangible Assets and Goodwill (Tables)	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	The components of our definite- and indefinite-lived intangible assets were as follows: September 30, 2022 December 31, 2021 (in thousands) Gross Accumulated Net Gross Accumulated Net Definite-lived Customer relationships $ 581,504 $ 395,810 $ 185,694 $ 593,242 $ 365,773 $ 227,469 Unpatented technologies 142,845 51,624 91,221 142,540 37,264 105,276 Favorable supply agreements 57,000 44,290 12,710 59,000 30,546 28,454 Trademarks 59,852 35,095 24,757 59,873 32,270 27,603 Patents 38,025 31,100 6,925 38,735 31,080 7,655 Other 5,242 5,193 49 5,390 5,177 213 884,468 563,112 321,356 898,780 502,110 396,670 Indefinite-lived Trademarks 3,600 — 3,600 3,600 — 3,600 In-process research and development 1,200 — 1,200 1,200 — 1,200 4,800 — 4,800 4,800 — 4,800 Total $ 889,268 $ 563,112 $ 326,156 $ 903,580 $ 502,110 $ 401,470
Schedule of Indefinite-Lived Intangible Assets	The components of our definite- and indefinite-lived intangible assets were as follows: September 30, 2022 December 31, 2021 (in thousands) Gross Accumulated Net Gross Accumulated Net Definite-lived Customer relationships $ 581,504 $ 395,810 $ 185,694 $ 593,242 $ 365,773 $ 227,469 Unpatented technologies 142,845 51,624 91,221 142,540 37,264 105,276 Favorable supply agreements 57,000 44,290 12,710 59,000 30,546 28,454 Trademarks 59,852 35,095 24,757 59,873 32,270 27,603 Patents 38,025 31,100 6,925 38,735 31,080 7,655 Other 5,242 5,193 49 5,390 5,177 213 884,468 563,112 321,356 898,780 502,110 396,670 Indefinite-lived Trademarks 3,600 — 3,600 3,600 — 3,600 In-process research and development 1,200 — 1,200 1,200 — 1,200 4,800 — 4,800 4,800 — 4,800 Total $ 889,268 $ 563,112 $ 326,156 $ 903,580 $ 502,110 $ 401,470
Schedule of Goodwill	The carrying amount of goodwill, including changes therein, by reportable segment is below: (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total December 31, 2021 $ 356,638 $ 205,467 $ 101,136 $ 39,626 $ 702,867 Acquisition (1) — 6,345 — — 6,345 Allocated to disposal group (2) (3,271) — — — (3,271) Foreign currency translation 3,192 (665) — (8) 2,519 September 30, 2022 $ 356,559 $ 211,147 $ 101,136 $ 39,618 $ 708,460 _______________________ (1) See Note 11—Acquisitions and Divestitures for additional information related to the acquisition of LSI completed during the first quarter of 2022. (2) See Note 11—Acquisitions and Divestitures for additional information on the reclassification of assets and liabilities held for sale as part of the planned divestiture of our operations in Russia.

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	Long-term debt consisted of the following: (in thousands) September 30, 2022 December 31, 2021 2022 Revolving Credit Facility $ 45,000 $ — 2018 Term Loan Facility — 140,000 2020 Term Loan Facility — 496,725 2022 Term Loan Facility 625,000 — 6.375% Senior Notes due 2026 — 92,041 Total 670,000 728,766 Net unamortized discounts and issuance costs (21,283) (4,259) Total long-term debt 648,717 724,507 Current portion of long-term debt (1) (4,688) (26,850) Long-term debt, less current portion $ 644,029 $ 697,657 _______________________ (1) Represents the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of September 30, 2022 and 2020 Term Loan Facility as of December 31, 2021.

Restructuring and Other Relat_2

Restructuring and Other Related Charges (Tables)	9 Months Ended
Restructuring and Other Related Charges (Tables)	Sep. 30, 2022
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	The following table presents the restructuring and other related charges by segment as classified in our condensed consolidated statements of income. Three Months Ended Nine Months Ended (in thousands) 2022 2021 2022 2021 Segment restructuring charges (income): Production Chemical Technologies $ (335) $ 1,031 $ 11,637 $ 4,822 Production & Automation Technologies 4,282 947 260 4,903 Drilling Technologies — — — — Reservoir Chemical Technologies 63,458 65 69,559 307 Corporate and other 2,350 44 3,403 86 Total $ 69,755 $ 2,087 $ 84,859 $ 10,118 Statements of Income classification: Cost of goods and services $ 66,488 $ 802 $ 67,496 $ 4,708 Selling, general and administrative expense 3,267 1,285 17,363 5,410 Total $ 69,755 $ 2,087 $ 84,859 $ 10,118 The following table details our restructuring accrual activities during the nine months ended September 30, 2022: (in thousands) Restructuring Accrual Balance December 31, 2021 $ 3,743 Restructuring charges 84,859 Asset sales (13,235) Payments (13,771) Other, including foreign currency translation (66) September 30, 2022 $ 61,530

Equity and Cash Incentive Pro_2

Equity and Cash Incentive Programs (Tables)	9 Months Ended
Equity and Cash Incentive Programs (Tables)	Sep. 30, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense relating to all stock-based incentive plans was as follows: Three Months Ended Nine Months Ended (in thousands) 2022 2021 2022 2021 Stock-based compensation expense $ 5,009 $ 5,557 $ 14,808 $ 17,913 Tax benefit (1,052) (1,167) (3,110) (3,762) Stock-based compensation expense, net of tax $ 3,957 $ 4,390 $ 11,698 $ 14,151
Summary of Activity Related to Share-Based Awards	A summary of activity relating to our share-based awards for the nine months ended September 30, 2022 was as follows: (in shares) Stock-Settled Appreciation Rights Performance Share Awards Restricted Stock Units Non-Qualified Stock Options Outstanding at January 1, 2022 393,523 505,509 2,342,107 5,488,653 Granted — 347,920 945,616 — Forfeited / expired (1,758) (6,022) (226,671) (2,859) Exercised / vested — (72,410) (466,898) (586,064) Outstanding at September 30, 2022 391,765 774,997 2,594,154 4,899,730

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
Stockholders' Equity (Tables)	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Schedule of Accumulated Other Comprehensive Loss	Accumulated other comprehensive loss consisted of the following: (in thousands) Foreign Currency Translation Defined Pension and Other Post-Retirement Benefits Cash Flow Hedges Accumulated Other Comprehensive Loss December 31, 2021 $ (19,430) $ (3,476) $ 1,281 $ (21,625) Other comprehensive loss before reclassifications, net of tax (1,565) — (1,299) (2,864) Reclassification adjustment for net losses included in net income, net of tax — 69 — 69 Other comprehensive loss, net of tax (1,565) 69 (1,299) (2,795) March 31, 2022 $ (20,995) $ (3,407) $ (18) $ (24,420) Other comprehensive income before reclassifications, net of tax 21,169 — (3,403) 17,766 Reclassification adjustment for net losses included in net income, net of tax — 70 — 70 Other comprehensive income, net of tax 21,169 70 (3,403) 17,836 June 30, 2022 $ 174 $ (3,337) $ (3,421) $ (6,584) Other comprehensive income before reclassifications, net of tax $ (47,067) $ — $ 16,310 $ (30,757) Reclassification adjustment for net losses included in net income, net of tax $ — $ 68 $ — $ 68 Other comprehensive income, net of tax (47,067) 68 16,310 (30,689) September 30, 2022 $ (46,893) $ (3,269) $ 12,889 $ (37,273) (in thousands) Foreign Currency Translation Defined Pension and Other Post-Retirement Benefits Cash Flow Hedges Accumulated Other Comprehensive Loss December 31, 2020 $ (14,965) $ (13,470) $ (2,320) $ (30,755) Other comprehensive income before reclassifications, net of tax 3,213 — 413 3,626 Reclassification adjustment for net losses included in net income, net of tax — 167 — 167 Other comprehensive income, net of tax 3,213 167 413 3,793 March 31, 2021 $ (11,752) $ (13,303) $ (1,907) $ (26,962) Other comprehensive income (loss) before reclassifications, net of tax 8,332 — (277) 8,055 Reclassification adjustment for net losses included in net income, net of tax — 6,373 — 6,373 Other comprehensive income (loss), net of tax 8,332 6,373 (277) 14,428 June 30, 2021 $ (3,420) $ (6,930) $ (2,184) $ (12,534) Other comprehensive income (loss) before reclassifications, net of tax (11,737) — 3,218 (8,519) Reclassification adjustment for net losses included in net income, net of tax — 46 — 46 Other comprehensive income (loss), net of tax (11,737) 46 3,218 (8,473) September 30, 2021 $ (15,157) $ (6,884) $ 1,034 $ (21,007)
Schedule of Reclassifications from Accumulated Other Comprehensive Loss	Reclassification adjustments from accumulated other comprehensive loss to net income (loss) related to defined pension and other post-retirement benefits consisted of the following: Three Months Ended Nine Months Ended Affected line items on the condensed consolidated statements of income (loss) (in thousands) 2022 2021 2022 2021 Pensions and other post-retirement benefits: Amortization of actuarial loss and other $ 68 $ 46 $ 207 $ 6,586 Other expense (income), net Total before tax 68 46 207 6,586 Income before income taxes Tax benefit — — — — Provision for income taxes Net of tax $ 68 $ 46 $ 207 $ 6,586 Net income

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
Earnings Per Share (Tables)	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Earnings per Share	A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands, except per share data) 2022 2021 2022 2021 Net income attributable to ChampionX $ 23,068 $ 56,828 $ 87,112 $ 69,850 Weighted-average number of shares outstanding 201,421 201,852 202,600 201,329 Dilutive effect of stock-based compensation 5,101 6,693 5,555 6,844 Total shares and dilutive securities 206,522 208,545 208,155 208,173 Earnings per share attributable to ChampionX: Basic $ 0.11 $ 0.28 $ 0.43 $ 0.35 Diluted $ 0.11 $ 0.27 $ 0.42 $ 0.34

Acquisitions and Divestitures (

Acquisitions and Divestitures (Tables)	9 Months Ended
Acquisitions and Divestitures (Tables)	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Major Class of Assets and Liabilities Held For Sale	The following table presents information related to the major classes of assets and liabilities of the CT Russia Business that were held for sale in our condensed consolidated balance sheet: (in thousands) Receivables $ 8,330 Inventory 6,638 Prepaid expenses and other current assets 3,078 Property, plant, and equipment 4,721 Goodwill 3,271 Intangible assets 6,927 Operating lease right-of-use assets 2,001 Loss on disposal group (16,515) Total assets held for sale $ 18,451 Accounts payable $ 2,168 Other current liabilities 3,933 Other noncurrent liabilities 3,257 Total liabilities held for sale $ 9,358

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured on Recurring Basis	The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows: Carrying Amount (in thousands) Measurement Level September 30, 2022 December 31, 2021 Assets Foreign currency forward contracts Level 2 $ 17,074 $ 4,081 Interest rate swaps Level 2 8,885 — Total $ 25,959 $ 4,081 Liabilities Foreign currency forward contracts Level 2 $ 11,989 $ 3,773 Interest rate swaps Level 2 133 — Total $ 12,122 $ 3,773
Schedule of Fair Value of Long-Term Debt	The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were: September 30, 2022 December 31, 2021 (in thousands) Carrying Amount Fair Value Carrying Amount Fair Value 2022 Revolving Credit Facility $ 45,000 $ 45,000 $ — $ — 2018 Term Loan Facility $ — $ — $ 140,000 $ 138,950 2020 Term Loan Facility $ — $ — $ 496,725 $ 502,313 2022 Term Loan Facility $ 625,000 $ 609,375 $ — $ — 6.375% Senior Notes due 2026 $ — $ — $ 92,041 $ 95,805

Derivatives and Hedging Trans_2

Derivatives and Hedging Transactions (Tables)	9 Months Ended
Derivatives and Hedging Transactions (Tables)	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Values of Outstanding Derivatives	The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet. Derivative Assets Derivative Liabilities (in thousands) September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 Prepaid expenses and other current assets $ 20,027 $ 4,081 $ — $ — Other non-current assets 5,932 — — — Accrued expenses and other current liabilities — — 12,122 3,773 Other long-term liabilities — — — — $ 25,959 $ 4,081 $ 12,122 $ 3,773 The following table summarizes the notional values of the Company’s outstanding derivatives: (in thousands) September 30, 2022 December 31, 2021 Notional value of foreign currency forward contracts and interest rate swaps $ 953,246 $ 704,190
Schedule of Derivative Instruments	The loss of all derivative instruments recognized is summarized below: Three Months Ended Nine Months Ended (in thousands) 2022 2021 2022 2021 Loss (gain) reclassified from AOCI to income on cash flow hedges: Cost of goods and services $ (837) $ 1,447 $ (884) $ 3,219 Interest expense 585 — 585 — Loss on derivatives not designated as hedging instruments: Other (income) expense, net 1,167 955 6,578 2,417 Total loss of derivative instruments $ 915 $ 2,402 $ 6,279 $ 5,636

Inventories (Tables)

Inventories (Tables)	9 Months Ended
Inventories (Tables)	Sep. 30, 2022
Inventory, Net [Abstract]
Components of Inventory	Inventories consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Raw materials $ 148,119 $ 186,516 Work in progress 20,363 13,615 Finished goods 523,042 421,702 691,524 621,833 Inventory reserve (26,927) (24,646) LIFO adjustments (1) (93,777) (54,277) Inventories, net $ 570,820 $ 542,910 _______________________ (1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.

Segment Information (Details)

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Segment Information (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment revenue:
Revenue	$ 1,021,561	$ 818,785	$ 2,820,093	$ 2,252,845
Segment operating profit (loss):
Interest expense, net	11,454	12,849	33,582	40,884
Income before income taxes	37,471	84,561	109,529	102,729
Operating Segments
Segment operating profit (loss):
Income before income taxes	62,279	109,049	186,155	195,364
Operating Segments \| Production Chemical Technologies
Segment revenue:
Revenue	643,604	487,670	1,710,987	1,347,090
Segment operating profit (loss):
Income before income taxes	86,649	45,696	143,518	109,924
Operating Segments \| Production & Automation Technologies
Segment revenue:
Revenue	247,717	204,473	710,465	559,491
Segment operating profit (loss):
Income before income taxes	22,485	14,407	70,845	32,061
Operating Segments \| Drilling Technologies
Segment revenue:
Revenue	60,965	49,415	175,682	121,998
Segment operating profit (loss):
Income before income taxes	14,856	11,146	45,119	21,400
Operating Segments \| Reservoir Chemical Technologies
Segment revenue:
Revenue	35,485	38,192	119,499	101,305
Segment operating profit (loss):
Income before income taxes	(61,711)	37,800	(73,327)	31,979
Corporate and Other
Segment revenue:
Revenue	33,790	39,035	103,460	122,961
Segment operating profit (loss):
Income before income taxes	$ 13,354	$ 11,639	$ 43,044	$ 51,751

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,021,561	$ 818,785	$ 2,820,093	$ 2,252,845
United States
Disaggregation of Revenue [Line Items]
Total revenue	507,973	412,656	1,450,939	1,134,323
Latin America
Disaggregation of Revenue [Line Items]
Total revenue	193,975	119,802	437,922	303,277
Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	103,963	88,834	306,600	259,345
Canada
Disaggregation of Revenue [Line Items]
Total revenue	99,253	88,231	292,161	247,645
Europe
Disaggregation of Revenue [Line Items]
Total revenue	63,442	57,540	181,586	158,181
Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	20,899	22,672	65,841	64,547
Australia
Disaggregation of Revenue [Line Items]
Total revenue	16,351	18,114	41,951	49,475
Other
Disaggregation of Revenue [Line Items]
Total revenue	15,705	10,936	43,093	36,052
Corporate and other
Disaggregation of Revenue [Line Items]
Total revenue	33,790	39,035	103,460	122,961
Corporate and other \| United States
Disaggregation of Revenue [Line Items]
Total revenue	19,651	26,890	61,544	83,132
Corporate and other \| Latin America
Disaggregation of Revenue [Line Items]
Total revenue	758	1,048	2,388	3,740
Corporate and other \| Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	1,358	1,467	1,959	8,534
Corporate and other \| Canada
Disaggregation of Revenue [Line Items]
Total revenue	49	43	112	325
Corporate and other \| Europe
Disaggregation of Revenue [Line Items]
Total revenue	3,584	3,529	10,352	9,476
Corporate and other \| Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	8,390	6,058	27,105	17,754
Corporate and other \| Australia
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Corporate and other \| Other
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Production Chemical Technologies \| Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	643,604	487,670	1,710,987	1,347,090
Production Chemical Technologies \| Operating Segments \| United States
Disaggregation of Revenue [Line Items]
Total revenue	228,007	163,184	624,370	469,900
Production Chemical Technologies \| Operating Segments \| Latin America
Disaggregation of Revenue [Line Items]
Total revenue	184,964	110,592	409,109	275,597
Production Chemical Technologies \| Operating Segments \| Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	77,162	66,584	227,234	191,167
Production Chemical Technologies \| Operating Segments \| Canada
Disaggregation of Revenue [Line Items]
Total revenue	75,334	68,907	223,714	193,838
Production Chemical Technologies \| Operating Segments \| Europe
Disaggregation of Revenue [Line Items]
Total revenue	50,206	47,891	145,116	131,545
Production Chemical Technologies \| Operating Segments \| Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	8,851	11,703	26,852	32,757
Production Chemical Technologies \| Operating Segments \| Australia
Disaggregation of Revenue [Line Items]
Total revenue	5,518	8,693	16,321	21,082
Production Chemical Technologies \| Operating Segments \| Other
Disaggregation of Revenue [Line Items]
Total revenue	13,562	10,116	38,271	31,204
Production & Automation Technologies \| Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	247,717	204,473	710,465	559,491
Production & Automation Technologies \| Operating Segments \| United States
Disaggregation of Revenue [Line Items]
Total revenue	192,914	158,534	548,698	426,246
Production & Automation Technologies \| Operating Segments \| Latin America
Disaggregation of Revenue [Line Items]
Total revenue	4,963	4,752	16,324	13,924
Production & Automation Technologies \| Operating Segments \| Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	15,567	14,243	51,340	38,346
Production & Automation Technologies \| Operating Segments \| Canada
Disaggregation of Revenue [Line Items]
Total revenue	18,922	14,922	55,858	42,204
Production & Automation Technologies \| Operating Segments \| Europe
Disaggregation of Revenue [Line Items]
Total revenue	2,776	731	8,505	4,504
Production & Automation Technologies \| Operating Segments \| Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	1,528	1,853	3,983	6,059
Production & Automation Technologies \| Operating Segments \| Australia
Disaggregation of Revenue [Line Items]
Total revenue	10,803	9,393	25,386	28,151
Production & Automation Technologies \| Operating Segments \| Other
Disaggregation of Revenue [Line Items]
Total revenue	244	45	371	57
Drilling Technologies \| Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	60,965	49,415	175,682	121,998
Drilling Technologies \| Operating Segments \| United States
Disaggregation of Revenue [Line Items]
Total revenue	47,645	37,716	140,312	93,515
Drilling Technologies \| Operating Segments \| Latin America
Disaggregation of Revenue [Line Items]
Total revenue	7	0	7	0
Drilling Technologies \| Operating Segments \| Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	1,562	1,582	4,471	3,744
Drilling Technologies \| Operating Segments \| Canada
Disaggregation of Revenue [Line Items]
Total revenue	4,614	3,697	11,032	9,510
Drilling Technologies \| Operating Segments \| Europe
Disaggregation of Revenue [Line Items]
Total revenue	5,774	4,459	14,640	9,236
Drilling Technologies \| Operating Segments \| Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	1,363	1,945	5,180	4,351
Drilling Technologies \| Operating Segments \| Australia
Disaggregation of Revenue [Line Items]
Total revenue	0	0	15	130
Drilling Technologies \| Operating Segments \| Other
Disaggregation of Revenue [Line Items]
Total revenue	0	16	25	1,512
Reservoir Chemical Technologies \| Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	35,485	38,192	119,499	101,305
Reservoir Chemical Technologies \| Operating Segments \| United States
Disaggregation of Revenue [Line Items]
Total revenue	19,756	26,332	76,015	61,530
Reservoir Chemical Technologies \| Operating Segments \| Latin America
Disaggregation of Revenue [Line Items]
Total revenue	3,283	3,410	10,094	10,016
Reservoir Chemical Technologies \| Operating Segments \| Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	8,314	4,958	21,596	17,554
Reservoir Chemical Technologies \| Operating Segments \| Canada
Disaggregation of Revenue [Line Items]
Total revenue	334	662	1,445	1,768
Reservoir Chemical Technologies \| Operating Segments \| Europe
Disaggregation of Revenue [Line Items]
Total revenue	1,102	930	2,973	3,420
Reservoir Chemical Technologies \| Operating Segments \| Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	767	1,113	2,721	3,626
Reservoir Chemical Technologies \| Operating Segments \| Australia
Disaggregation of Revenue [Line Items]
Total revenue	30	28	229	112
Reservoir Chemical Technologies \| Operating Segments \| Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,899	$ 759	$ 4,426	$ 3,279

Revenue - Contract Balances (De

Revenue - Contract Balances (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract assets	$ 0	$ 0
Contract liabilities - current	$ 13,660	$ 15,246

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Schedule of Intangibles (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 884,468	$ 898,780
Accumulated Amortization	563,112	502,110
Net Carrying Amount	321,356	396,670
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	4,800	4,800
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible assets, gross	889,268	903,580
Accumulated Amortization	563,112	502,110
Intangible assets, net	326,156	401,470
Trademarks
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	3,600	3,600
In-process research and development
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	1,200	1,200
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	581,504	593,242
Accumulated Amortization	395,810	365,773
Net Carrying Amount	185,694	227,469
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	395,810	365,773
Unpatented technologies
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	142,845	142,540
Accumulated Amortization	51,624	37,264
Net Carrying Amount	91,221	105,276
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	51,624	37,264
Favorable supply agreements
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	57,000	59,000
Accumulated Amortization	44,290	30,546
Net Carrying Amount	12,710	28,454
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	44,290	30,546
Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	59,852	59,873
Accumulated Amortization	35,095	32,270
Net Carrying Amount	24,757	27,603
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	35,095	32,270
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	38,025	38,735
Accumulated Amortization	31,100	31,080
Net Carrying Amount	6,925	7,655
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	31,100	31,080
Other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	5,242	5,390
Accumulated Amortization	5,193	5,177
Net Carrying Amount	49	213
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ 5,193	$ 5,177

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 702,867
Acquisition	6,345
Allocated to disposal group	(3,271)
Foreign currency translation	2,519
Ending balance	708,460
Production Chemical Technologies
Goodwill [Roll Forward]
Beginning balance	356,638
Acquisition	0
Allocated to disposal group	(3,271)
Foreign currency translation	3,192
Ending balance	356,559
Production & Automation Technologies
Goodwill [Roll Forward]
Beginning balance	205,467
Acquisition	6,345
Allocated to disposal group	0
Foreign currency translation	(665)
Ending balance	211,147
Drilling Technologies
Goodwill [Roll Forward]
Beginning balance	101,136
Acquisition	0
Allocated to disposal group	0
Foreign currency translation	0
Ending balance	101,136
Reservoir Chemical Technologies
Goodwill [Roll Forward]
Beginning balance	39,626
Acquisition	0
Allocated to disposal group	0
Foreign currency translation	(8)
Ending balance	$ 39,618

Debt - Long-term Debt (Details)

Debt - Long-term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	$ 670,000	$ 728,766
Net unamortized discounts and issuance costs	(21,283)	(4,259)
Total long-term debt	648,717	724,507
Current portion of long-term debt	(4,688)	(26,850)
Long-term debt, less current portion	644,029	697,657
Credit Facility \| 2022 Revolving Credit Facility \| Revolving Credit Facility
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	45,000	0
Term Loan Facility \| 2018 Term Loan Facility
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	0	140,000
Term Loan Facility \| 2020 Term Loan Facility
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	0	496,725
Term Loan Facility \| 2022 Term Loan Facility
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	$ 625,000	$ 0
Senior Notes \| 6.375% Senior Notes due 2026
Debt Instrument [Line Items]
Debt interest rate	6.375%	6.375%
Long-term Debt and Lease Obligation	$ 0	$ 92,041

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)				9 Months Ended
Debt - Narrative (Details) - USD ($)	Jun. 29, 2022	Jun. 07, 2022	May 09, 2018	Sep. 30, 2022	Dec. 31, 2021	Jun. 03, 2020
Debt Instrument [Line Items]
Carrying Amount				$ 670,000,000	$ 728,766,000
Interest rate swaps \| Designated as Hedging Instrument
Debt Instrument [Line Items]
Derivative instrument, term (in years)	5 years
Interest Rate Swap, First Three Years \| Designated as Hedging Instrument
Debt Instrument [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps	$ 300,000,000
Interest Rate Swap, Years Four And Five \| Designated as Hedging Instrument
Debt Instrument [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps	$ 150,000,000
Credit Agreement \| Term Loan Facility
Debt Instrument [Line Items]
Debt instrument, term (in years)			7 years
2018 Term Loan Facility \| Term Loan Facility
Debt Instrument [Line Items]
Principal amount of debt issued			$ 415,000,000
Carrying Amount				0	140,000,000
2020 Term Loan Facility \| Term Loan Facility
Debt Instrument [Line Items]
Principal amount of debt issued						$ 537,000,000
Carrying Amount				0	496,725,000
2022 Term Loan Facility \| Term Loan Facility
Debt Instrument [Line Items]
Debt instrument, term (in years)		7 years
Principal amount of debt issued		$ 625,000,000
Carrying Amount				625,000,000	0
Mandatory amortization payment, percent per annum		1%
2022 Revolving Credit Facility \| Credit Facility \| Revolving Credit Facility
Debt Instrument [Line Items]
Debt instrument, term (in years)		5 years
Maximum borrowing capacity		$ 700,000,000
Borrowings from lines of credit		135,000,000
Carrying Amount				$ 45,000,000	$ 0
2022 Revolving Credit Facility \| Credit Facility \| Letter of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 100,000,000
6.375% Senior Notes due 2026 \| Senior Notes
Debt Instrument [Line Items]
Debt interest rate				6.375%	6.375%
Carrying Amount				$ 0	$ 92,041,000
Redemption price, percentage of principal amount of debt		103.188%
Aggregate principal amount repurchased		$ 92,000,000
Amount of principal debt repurchased		95,600,000
Accrued interest paid on repurchase		$ 600,000
Net loss from repurchases of debt				$ 3,900,000

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	9 Months Ended
Commitments and Contingencies (Details) $ in Millions	Sep. 30, 2022 USD ($) case location	Dec. 31, 2021 USD ($)	Dec. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Outstanding letters of credit, surety bonds and guarantees	$ 73	$ 80.2
Number of locations participating in assessments and remediation \| location	11
Accrued environmental liability	$ 6.1	$ 6.8	$ 2
Number of pending cases \| case	2

Restructuring and Other Relat_3

Restructuring and Other Related Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 69,755	$ 2,087	$ 84,859	$ 10,118
Minimum
Restructuring Cost and Reserve [Line Items]
Contract termination liability, term (in years)			1 year
Maximum
Restructuring Cost and Reserve [Line Items]
Contract termination liability, term (in years)			8 years

Restructuring and Other Relat_4

Restructuring and Other Related Charges - Schedule of Restructuring and Other Related Charges (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 69,755	$ 2,087	$ 84,859	$ 10,118
Cost of goods and services
Restructuring Cost and Reserve [Line Items]
Restructuring charges	66,488	802	67,496	4,708
Selling, general and administrative expense
Restructuring Cost and Reserve [Line Items]
Restructuring charges	3,267	1,285	17,363	5,410
Corporate and other
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2,350	44	3,403	86
Production Chemical Technologies \| Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(335)	1,031	11,637	4,822
Production & Automation Technologies \| Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring charges	4,282	947	260	4,903
Drilling Technologies \| Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0	0	0
Reservoir Chemical Technologies \| Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 63,458	$ 65	$ 69,559	$ 307

Restructuring and Other Relat_5

Restructuring and Other Related Charges - Restructuring Reserve Rollforward (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Restructuring Accrual Balance
Beginning balance	$ 3,743
Restructuring charges	84,859
Asset sales	(13,235)
Payments	(13,771)
Other, including foreign currency translation	(66)
Ending balance	$ 61,530

Equity and Cash Incentive Pro_3

Equity and Cash Incentive Programs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stock-based compensation expense [Abstract]
Stock-based compensation expense	$ 5,009	$ 5,557	$ 14,808	$ 17,913
Tax benefit	(1,052)	(1,167)	(3,110)	(3,762)
Stock-based compensation expense, net of tax	$ 3,957	$ 4,390	$ 11,698	$ 14,151
Stock-Settled Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares)			393,523
Granted (in shares)			0
Forfeited / expired (in shares)			(1,758)
Exercised / vested (in shares)			0
Outstanding, ending balance (in shares)	391,765		391,765
Performance Share Awards
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares)			505,509
Granted (in shares)			347,920
Forfeited / expired (in shares)			(6,022)
Exercised / vested (in shares)			(72,410)
Outstanding, ending balance (in shares)	774,997		774,997
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares)			2,342,107
Granted (in shares)			945,616
Forfeited / expired (in shares)			(226,671)
Exercised / vested (in shares)			(466,898)
Outstanding, ending balance (in shares)	2,594,154		2,594,154
Non-Qualified Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares)			5,488,653
Granted (in shares)			0
Forfeited / expired (in shares)			(2,859)
Exercised / vested (in shares)			(586,064)
Outstanding, ending balance (in shares)	4,899,730		4,899,730

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended			9 Months Ended
	Aug. 11, 2022	Feb. 04, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2022	Oct. 24, 2022	Mar. 07, 2022
Class of Stock [Line Items]
Approved quarterly cash dividend (in dollars per share)		$ 0.075
Dividends declared to common shareholders (in dollars per share)	$ 0.075		$ 0.075	$ 0.075	$ 0.075
Dividends payable			$ 15,800			$ 15,800
Authorized amount of stock repurchase								$ 250,000
Repurchase and cancellation of common stock (in shares)			3,698,106			4,487,622
Weighted average price of common stock repurchased (in dollars per share)			$ 21.63			$ 22.28
Value of repurchased common stock			$ 80,074	$ 20,016		$ 100,100
Subsequent Event
Class of Stock [Line Items]
Authorized amount of stock repurchase							$ 750,000

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			$ 1,770,645				$ 1,770,645
Other comprehensive income	$ (30,689)	$ 17,836	(2,795)	$ (8,473)	$ 14,428	$ 3,793	(15,648)	$ 9,748
Ending balance	1,710,686						1,710,686
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(6,584)	(24,420)	(21,625)	(12,534)	(26,962)	(30,755)	(21,625)	(30,755)
Other comprehensive income (loss) before reclassifications, net of tax	(30,757)	17,766	(2,864)	(8,519)	8,055	3,626
Reclassification adjustment for net losses included in net income, net of tax	68	70	69	46	6,373	167
Other comprehensive income	(30,689)	17,836	(2,795)	(8,473)	14,428	3,793
Ending balance	(37,273)	(6,584)	(24,420)	(21,007)	(12,534)	(26,962)	(37,273)	(21,007)
Foreign Currency Translation
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	174	(20,995)	(19,430)	(3,420)	(11,752)	(14,965)	(19,430)	(14,965)
Other comprehensive income (loss) before reclassifications, net of tax	(47,067)	21,169	(1,565)	(11,737)	8,332	3,213
Reclassification adjustment for net losses included in net income, net of tax	0	0	0	0	0	0
Other comprehensive income	(47,067)	21,169	(1,565)	(11,737)	8,332	3,213
Ending balance	(46,893)	174	(20,995)	(15,157)	(3,420)	(11,752)	(46,893)	(15,157)
Defined Pension and Other Post-Retirement Benefits
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(3,337)	(3,407)	(3,476)	(6,930)	(13,303)	(13,470)	(3,476)	(13,470)
Other comprehensive income (loss) before reclassifications, net of tax	0	0	0	0	0	0
Reclassification adjustment for net losses included in net income, net of tax	68	70	69	46	6,373	167
Other comprehensive income	68	70	69	46	6,373	167
Ending balance	(3,269)	(3,337)	(3,407)	(6,884)	(6,930)	(13,303)	(3,269)	(6,884)
Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(3,421)	(18)	1,281	(2,184)	(1,907)	(2,320)	1,281	(2,320)
Other comprehensive income (loss) before reclassifications, net of tax	16,310	(3,403)	(1,299)	3,218	(277)	413
Reclassification adjustment for net losses included in net income, net of tax	0	0	0	0	0	0
Other comprehensive income	16,310	(3,403)	(1,299)	3,218	(277)	413
Ending balance	$ 12,889	$ (3,421)	$ (18)	$ 1,034	$ (2,184)	$ (1,907)	$ 12,889	$ 1,034

Stockholders' Equity - Reclassi

Stockholders' Equity - Reclassifications from Accumulated Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other expense (income), net	$ (6,118)			$ (36,876)			$ 27,483	$ (36,561)
Income before income taxes	(37,471)			(84,561)			(109,529)	(102,729)
Provision for income taxes	14,246			25,910			19,235	32,255
Net income	(23,225)	$ (28,896)	$ (38,173)	(58,651)	$ (7,786)	$ (4,037)	(90,294)	(70,474)
Amortization of actuarial loss and other \| Reclassification from accumulated other comprehensive loss
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other expense (income), net	68			46			207	6,586
Accumulated defined benefit plans adjustment including portion attributable to noncontrolling interest \| Reclassification from accumulated other comprehensive loss
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income before income taxes	68			46			207	6,586
Provision for income taxes	0			0			0	0
Net income	$ 68			$ 46			$ 207	$ 6,586

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Net income attributable to ChampionX	$ 23,068	$ 56,828	$ 87,112	$ 69,850
Weighted-average number of shares outstanding (in shares)	201,421	201,852	202,600	201,329
Dilutive effect of stock-based compensation (in shares)	5,101	6,693	5,555	6,844
Total shares and dilutive securities (in shares)	206,522	208,545	208,155	208,173
Basic (in dollars per share)	$ 0.11	$ 0.28	$ 0.43	$ 0.35
Diluted (in dollars per share)	$ 0.11	$ 0.27	$ 0.42	$ 0.34
Number of antidilutive securities excluded (in shares)	400	500	400	600

Acquisitions and Divestitures -

Acquisitions and Divestitures - Narrative (Details) - USD ($) $ in Thousands			3 Months Ended
	Feb. 23, 2023	Feb. 23, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill			$ 708,460		$ 702,867
Disposal Group, Held-for-sale, Not Discontinued Operations \| CT Russia Business
Business Acquisition [Line Items]
Charge on divestiture			$ 6,400	$ 22,900
Leak Surveys, Inc.
Business Acquisition [Line Items]
Amount paid for acquisition		$ 3,200
Future payments contingent upon performance		2,500
Goodwill		$ 6,300
Leak Surveys, Inc. \| Forecast
Business Acquisition [Line Items]
Amount paid for acquisition	$ 500

Acquisitions and Divestitures_2

Acquisitions and Divestitures - Schedule of Major Class of Assets and Liabilities Held For Sale (Details) - Disposal Group, Held-for-sale, Not Discontinued Operations - CT Russia Business $ in Thousands	Sep. 30, 2022 USD ($)
Business Acquisition [Line Items]
Receivables	$ 8,330
Inventory	6,638
Prepaid expenses and other current assets	3,078
Property, plant, and equipment	4,721
Goodwill	3,271
Intangible assets	6,927
Operating lease right-of-use assets	2,001
Loss on disposal group	(16,515)
Total assets held for sale	18,451
Accounts payable	2,168
Other current liabilities	3,933
Other noncurrent liabilities	3,257
Total liabilities held for sale	$ 9,358

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets
Derivative assets	$ 25,959	$ 4,081
Liabilities
Derivative liabilities	12,122	3,773
Carrying Amount	670,000	728,766
Credit Facility \| 2022 Revolving Credit Facility \| Revolving Credit Facility
Liabilities
Carrying Amount	45,000	0
Fair Value	45,000	0
Term Loan Facility \| 2018 Term Loan Facility
Liabilities
Carrying Amount	0	140,000
Term Loan Facility \| 2020 Term Loan Facility
Liabilities
Carrying Amount	0	496,725
Term Loan Facility \| 2022 Term Loan Facility
Liabilities
Carrying Amount	$ 625,000	$ 0
Senior Notes \| 6.375% Senior Notes due 2026
Liabilities
Debt interest rate	6.375%	6.375%
Carrying Amount	$ 0	$ 92,041
Level 2 \| Term Loan Facility \| 2018 Term Loan Facility
Liabilities
Fair Value	0	138,950
Level 2 \| Term Loan Facility \| 2020 Term Loan Facility
Liabilities
Fair Value	0	502,313
Level 2 \| Term Loan Facility \| 2022 Term Loan Facility
Liabilities
Fair Value	609,375	0
Level 1 \| Senior Notes \| 6.375% Senior Notes due 2026
Liabilities
Fair Value	0	95,805
Fair Value, Recurring \| Level 2
Assets
Derivative assets	25,959	4,081
Liabilities
Derivative liabilities	12,122	3,773
Foreign currency forward contracts \| Fair Value, Recurring \| Level 2
Assets
Derivative assets	17,074	4,081
Liabilities
Derivative liabilities	11,989	3,773
Interest rate swaps \| Fair Value, Recurring \| Level 2
Assets
Derivative assets	8,885	0
Liabilities
Derivative liabilities	$ 133	$ 0

Derivatives and Hedging Trans_3

Derivatives and Hedging Transactions - Schedule of Fair Value of Derivative Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Derivative Assets	$ 25,959	$ 4,081
Derivative Liabilities	12,122	3,773
Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative Assets	20,027	4,081
Other non-current assets
Derivatives, Fair Value [Line Items]
Derivative Assets	5,932	0
Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities	12,122	3,773
Other long-term liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities	$ 0	$ 0

Derivatives and Hedging Trans_4

Derivatives and Hedging Transactions - Schedule of Derivative Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Foreign Exchange Forward And Interest Rate Swap
Derivative [Line Items]
Notional value under derivative instrument agreement	$ 953,246	$ 704,190

Derivatives and Hedging Trans_5

Derivatives and Hedging Transactions - Schedule of Gain (Loss) on Derivative Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	$ 915	$ 2,402	$ 6,279	$ 5,636
Cost of goods and services \| Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	(837)	1,447	(884)	3,219
Interest expense \| Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	585	0	585	0
Other (income) expense, net \| Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	$ 1,167	$ 955	$ 6,578	$ 2,417

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventory, Net [Abstract]
Raw materials	$ 148,119	$ 186,516
Work in progress	20,363	13,615
Finished goods	523,042	421,702
Subtotal	691,524	621,833
Inventory reserve	(26,927)	(24,646)
LIFO adjustments	(93,777)	(54,277)
Inventories, net	$ 570,820	$ 542,910

Accounts Receivable Facility (D

Accounts Receivable Facility (Details) - Accounts receivable held for sale under Accounts Receivable Facility - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Jun. 28, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Maximum accounts receivable that can be sold			$ 160
Accounts receivable sold	$ 101.2	$ 101.2
Accounts receivable outstanding	60	60
Loss on sale of trade receivable	$ 0.7	$ 0.7

Cash Flow Information (Details)

Cash Flow Information (Details) - USD ($) $ in Millions	9 Months Ended
Cash Flow Information (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Supplemental Cash Flow Elements [Abstract]
Transfers from inventory	$ 32.1	$ 33.9